Arsenic Compounds as Therapeutic Agents

Ayodele Temidayo Odularu

Abstract


Abstract

The review looks into therapeutic effect of arsenic compounds from ancient time to contemporary era. Arsenic compounds are therapeutic agents that are multifaceted. Contributions and participation of selected chemists were aligned with the history of the use of arsenic compounds as therapeutic agent.

Keywords: Arsenic compounds, selected chemists, history, therapeutic agents


Full Text:

PDF

References


References

S. Gibaud and G. Jaouen, “Arsenic-Based Drugs: From Fowler’s Solution to Modern Anticancer Chemotherapy,” Topics in Organometallic Chemistry, vol. 32, pp. 1-20, 2010.

S. Chen, X. Yan and Z. Chen, “Arsenic in Therapy,” Encyclopedia of Metalloproteins, vol. 32, pp. 131-135, 2013.

O. Olaku and J. D. White, “Herbal Therapy Use by Cancer Patients: A Literature Review on Case Reports,” European Journal of Cancer, vol. 47, no. 4, pp. 508-514, 2011.

J. Zhu, Z. Chen, V. Lallemand-Breitenbach, H. Thé, “How Acute Promyelocytic Leukaemia Revived Arsenic.” Nature Review Cancer, vol. 2, no. 9, pp 705-714, 2002.

M. Edmonds, “The Evolution of Chemistry and Medicine in the 18th and 19th Centuries,” Chemistry in New Zealand, pp. 123-126, 2012.

S. Waxman and K. C. Anderson, “History of the Development of Arsenic Derivatives in Cancer Therapy,” Oncologist, vol. 6, pp. 3-10, 2001.

W. H. Miller, H. M. Schipper, J. S. Lee and S. Waxman, “Mechanisms of Action of Arsenic Trioxid,”Cancer Research, vol. 62, pp. 3893-3903, 2002.

M. F. Hughes, D. B. Barbara, Y. Chen, A. S. Lewis, D. J. Thomas, “Arsenic Exposure and Toxicity: A Historical Perspective.” Toxicological Sciences, vol. 123, no. 2, pp. 305-332, 2011.

H. Bhattacharjee, B. P. Rosen and R. Mukhopadhyay, “Aquaglyceroporins and Metalloid Transport: Implications in Human Diseases,” Handbook of Experimental Pharmacology, vol. 190, pp 309-325, 2009.

E. P. Swindell, P. L. Hankins, H. Chen; D. Miodragovic and T. V. O. Halloran, Anticancer Activity of Small Molecule and Nanoparticulate Arsenic(III) Complexes,” Inorganic Chemistry, vol. 52, no. 21, pp. 12292-12304, 2013.

G. B. Zhou,” Treatment of Acute Promyelocytic Leukaemia with All-trans Retinoic Acid and Arsenic Trioxide: A Paradigm of Synergistic Molecular Targeting Therapy,” Philosophical Transactions of the Royal Society, vol. 362, pp. 959-971, 2007.

B. Desoize, " Metals and Metal Compounds in Cancer Treatment,” Anticancer Research, vol. 24, no. 3a, pp. 1529-1544, 2004.

L. C. Platanias, “Biological Responses to Arsenic Compounds,” The Journal of Biological Chemistry, vol. 28, no. 28, pp. 18583-18587, 2007.

B. S. Sekhon, “Metalloids Compounds as Drugs,” Research in Pharmaceutical Sciences, vol. 8, no. 3, pp 145-158, 2013.

T. Zhang, G. Chen, Z. Wang, Z. Wang, S. Chen and Z. Che, “Arsenic Trioxide, a Therapeutic Agent for AP,” Oncogene, vol. 20, no 49, pp 7146-7153, 2001.

J. Hu, J. Fang, Y. Dong, S. J. Chen and Z. Chen, “Arsenic in Cancer Therapy,” Anti-Cancer Drugs, vol. 16, no. 2, pp 119-127, 2005.

N. P. E. Barry and P. Sadler, “Exploration of the Medical Periodic Table: towards New Targets,” Chemical Communications. vol. 49, pp. 5106-5131, 2013.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Ayodele Temidayo Odularu

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.